WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Renaming PCOS to PMOS—a 10‑year process of listening to patients and health professionals

A disease's name can have a significant influence on its diagnosis and treatment—or lack thereof. Polycystic ovary syndrome, or PCOS, is a condition that affects millions of people worldwide. For decades, doctors thought the condition mostly affected the ovaries, but its misleading name has left many people undiagnosed and at risk of developing several related chronic conditions at a young age.

Raccontata damedicalxpress.comwashingtonexaminer.comthehindu.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
medicalxpress.comStai leggendo1 g fa

Renaming PCOS to PMOS—a 10‑year process of listening to patients and health professionals

A 10-year international effort renamed PCOS to PMOS, targeting the 70% of 170M women currently undiagnosed. Clearer diagnostics enable systematic early screening, preventing metabolic disease and demonstrating how data-driven healthcare redefinition scales globally.

originale
thehindu.com1 g fa

The FemTech industry’s approach to PMOS

Discussions around PMOS rarely engage with broader environmental factors such as adulterated food, pollution, chronic stress, and toxins

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 29 maggio 2026·medicalxpress.com

    Not just ovaries—new name for PCOS reflects the condition's multisystem nature

    An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects…

  2. domenica 31 maggio 2026·washingtonexaminer.com

    Name tweak could boost GLP-1 access for one in eight women suffering PMOS

    The global effort to change the name of PCOS to PMOS might make GLP-1 weight loss drugs more accessible to women.

washingtonexaminer.com2 g fa

Name tweak could boost GLP-1 access for one in eight women suffering PMOS

The global effort to change the name of PCOS to PMOS might make GLP-1 weight loss drugs more accessible to women.

Leggi questa versione → originale
  • lunedì 1 giugno 2026·medicalxpress.com

    Renaming PCOS to PMOS—a 10‑year process of listening to patients and health professionals

    A disease's name can have a significant influence on its diagnosis and treatment—or lack thereof. Polycystic ovary syndrome, or PCOS, is a condition that affects millions of…

  • lunedì 1 giugno 2026·thehindu.com

    The FemTech industry’s approach to PMOS

    Discussions around PMOS rarely engage with broader environmental factors such as adulterated food, pollution, chronic stress, and toxins